Research theme for competitive and other funds (1)：
2015 - 2018 Effective combination of heavy ion beams and anti-VEGF antibody by targeting neural tumor stem cells
Papers (25)：
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Kenta Onishi, Makito Miyake, Kaori Yamaki, Kiyohide Fujimoto. Prostate-specific antigen (PSA) nadir and experience of PSA bounce after low-dose-rate brachytherapy for prostate cancer predicts clinical failure. Brachytherapy. 2024
Kenta Onishi, Yasushi Nakai, Fumisato Maesaka, Mitsuru Tomizawa, Takuto Shimizu, Shunta Hori, Daisuke Gotoh, Makito Miyake, Kaori Yamaki, Isao Asakawa, et al. Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer. Japanese journal of clinical oncology. 2024
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Kenta Ohnishi, Makito Miyake, Kaori Yamaki, Kazumasa Torimoto, Kiyohide Fujimoto. Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matching. The Prostate. 2024
Ryosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, Nobuyoshi Inooka, Takayuki Morimoto, Ryosuke Maeoka, Tsutomu Nakazawa, Tomoko Ochi, Toshiteru Miyasaka, Shigeto Hontsu, et al. Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study. World Neurosurgery. 2024. 183. e944-e952
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Shunta Hori, Makito Miyake, Kaori Yamaki, Satoshi Anai, Kazumasa Torimoto, Takeshi Inoue, Masatoshi Hasegawa, et al. Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy. The Prostate. 2023. 83. 7. 701-712
